For those who are interested, there’s a very readable article on the Bloomberg web site today entitled “What if what you ’survived’ wasn’t cancer?” The author expands on the idea that we might want to be reconsidering the importance of early detection of low-risk forms of “cancer” and the taxonomy of the word “cancer” itself.
-
-
-
-
-
-
- The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
A service of
Awards
Other PCI web sites
One Response
Leave a Reply Cancel reply
This site uses Akismet to reduce spam. Learn how your comment data is processed.
-
PCaI’s ASVSG
If you are on or thinking about active surveillance (AS) as a way to manage your low-risk prostate cancer, you may want to join Prostate Cancer International’s Active Surveillance Virtual Support Group.
CureTalks on PCa
Our most recent CureTalk on Prostate Cancer (on February 21 this year) features Eli Van Allen, MD, of the Broad Institute and the Dana-Farber Cancer Center, talking about the new “Metastatic Prostate Cancer Project” and how you can become part of the solution.
For access to the full list of CureTalks on Prostate Cancer, please click here.
Disclaimer
News and information provided on this site should not be used for diagnosing or treating any health problem or disease.
The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.
-
Hot Posts …
- A follow-up on active surveillance and the MEAL study
- Beyond PSMA — FAPI theranostics
- Why lutetium-177-PSMA treatment sometimes may not help, and may even harm
- FDA approves enzalutamide for treatment of metastatic HSPC
- Diabetes and risk for prostate cancer
- Risk for prostate cancer in men under 40 years of age
- InfoLink information hiatus
- Gone but by no means forgotten
- “Adjuvant” similar to “early salvage” radiation outcome in meta-analysis
- Data from the PROfound trial reported at ESMO
- Risk for early onset prostate cancer MAY BE increased in some infertile men
- The first-line treatment of locally advanced prostate cancer (clinical stage T3)
- Projecting risk for metastasis after radical prostatectomy
- The celebrity prostate cancer line-up … and what they actually say
- Moving targets and the interpretation of “new” medical “knowledge”
… and Archives
Blog at WordPress.com. WP Designer.
So glad to see this issue emerging in mainstream media. While over-diagnosis is a great way to sell a lot of product, the cost in pain, suffering, diminished wealth, and quality of life are very, very real. Further, cancer over-diagnosis is an unsustainable business model at the public health and healthcare financing levels.
Alas, the desire to buy and sell snake oil seems endemic to the human condition. Perhaps we can just shift to a format without such long-term consequences for those who take the bait.